Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Hydrochlorothiazide/triamterene

From Wikipedia, the free encyclopedia
(Redirected fromDyazide)
Combination medication

Pharmaceutical compound
Hydrochlorothiazide/triamterene
Combination of
HydrochlorothiazideThiazidediuretic
TriamterenePotassium-sparing diuretic
Clinical data
Trade namesDyazide, Maxzide, others
Other namesco-triamterzide
AHFS/Drugs.comProfessional Drug Facts
License data
Pregnancy
category
Routes of
administration
By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Hydrochlorothiazide/triamterene, also known asco-triamterzide, is afixed-dose combination medication ofhydrochlorothiazide andtriamterene.[1][2][3] It is used to treathigh blood pressure andedema (swelling).[1][2][3] Specifically it is used in those who developlow blood potassium (hypokalemia) when on only hydrochlorothiazide.[1][2] It is takenby mouth.[1][2][3]

Side effects may include nausea, trouble sleeping, dizziness,feeling light headed with standing, kidney problems,allergies, and muscle cramps.[1][2] Other serious side effects may includehigh blood potassium.[1][2] Use inpregnancy andbreastfeeding is not generally recommended.[1][2] Use in those with significant kidney problems is not recommended.[1][2] It decreases blood pressure mainly by hydrochlorothiazide while triamterene decreases the amount of potassium lost.[1][2]

The combination was approved for medical use in the United States in 1965.[4] In 2023, it was the 115th most commonly prescribed medication in the United States, with more than 5 million prescriptions.[5][6]

References

[edit]
  1. ^abcdefghij"Dyazide- hydrochlorothiazide and triamterene capsule".DailyMed. 31 October 2017. Retrieved20 August 2020.
  2. ^abcdefghij"Maxzide-25- maxzide tablet Maxzide tablet".DailyMed. 20 July 2018. Retrieved20 August 2020.
  3. ^abcBritish national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 76.ISBN 9780857113382.
  4. ^"Dyazide: FDA-Approved Drugs".U.S.Food and Drug Administration (FDA). Archived fromthe original on 17 February 2017. Retrieved20 August 2020.
  5. ^"Top 300 of 2023".ClinCalc.Archived from the original on 12 August 2025. Retrieved12 August 2025.
  6. ^"Hydrochlorothiazide; Triamterene Drug Usage Statistics, United States, 2013 - 2023".ClinCalc. Retrieved18 August 2025.
Sulfonamides
(andetacrynic acid)
CA inhibitors (atPT)
Loop (Na-K-Cl atAL)
Thiazides (Na-Cl atDCT,
Calcium-sparing)
Thiazide-likes (primarilyDCT)
Potassium-sparing (atCD)
ESC blockers
Aldosterone antagonists
Osmotic diuretics (PT,DL)
Vasopressin receptor inhibitors
(DCT andCD)
Other
Combination products
Subsidiaries
Current
Former
Predecessors,
acquisitions
Products
Current
Pharma
Vaccines
Former
People
Board of
Directors
Other
Litigation
Other
Portal:
Retrieved from "https://en.wikipedia.org/w/index.php?title=Hydrochlorothiazide/triamterene&oldid=1306598140"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp